Cargando…

Persistence with statin therapy in Hungary

INTRODUCTION: Persistence with lipid-lowering drug therapy by cardiovascular patients in Hungary has not been studied previously. This study was designed to determine the rate with which Hungarian patients with hyperlipidemia persist in taking lipid-lowering agents, and to compare this with rates re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Zoltan, Nagy, Laszlo, Reiber, Istvan, Paragh, György, Molnar, Mark Peter, Rokszin, György, Abonyi-Toth, Zsolt, Mark, Laszlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701976/ https://www.ncbi.nlm.nih.gov/pubmed/23847660 http://dx.doi.org/10.5114/aoms.2013.35327

Ejemplares similares

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
por: Barkai, László, et al.
Publicado: (2019)

An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS Program
por: Mark, Laszlo, et al.
Publicado: (2011)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
por: Kiss, Zoltan, et al.
Publicado: (2019)

Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008
por: Mark, Laszlo, et al.
Publicado: (2010)

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
por: Kiss, Zoltán, et al.
Publicado: (2018)

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis
por: Jermendy, György, et al.
Publicado: (2022)

How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?
por: Mark, Laszlo, et al.
Publicado: (2012)

Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol
por: Reiber, Istvan, et al.
Publicado: (2020)

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
por: Jermendy, György, et al.
Publicado: (2018)

Lung cancer drug therapy in Hungary – 3-year experience
por: Moldvay, Judit, et al.
Publicado: (2015)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
por: Tamási, Lilla, et al.
Publicado: (2021)

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
por: Kiss, Zoltan, et al.
Publicado: (2021)

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
por: Vokó, Zoltán, et al.
Publicado: (2022)

Oral Anticoagulant Therapy and Bleeding Events with Vitamin K Antagonists in Patients with Atrial Fibrillation in a Hungarian County Hospital
por: Mark, Laszlo, et al.
Publicado: (2015)

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
por: Kiss, Zolta´n, et al.
Publicado: (2022)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Preventive Metformin Monotherapy Medication Prescription, Redemption and Socioeconomic Status in Hungary in 2018–2019: A Cross-Sectional Study
por: Nagy, Csilla, et al.
Publicado: (2021)

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
por: Liszkay, Gabriella, et al.
Publicado: (2021)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study
por: Sütő, Gábor, et al.
Publicado: (2021)

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study
por: Rokszin, György, et al.
Publicado: (2021)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

Clinicopathological Review of 547 Bulbar Enucleations in Hungary (2006–2017)
por: Tóth, Gábor, et al.
Publicado: (2019)

Clinical Review of Ocular Traumas Resulting in Enucleation or Evisceration in a Tertiary Eye Care Center in Hungary
por: Tóth, Gábor, et al.
Publicado: (2021)

Clinical Review of Microbial Corneal Ulcers Resulting in Enucleation and Evisceration in a Tertiary Eye Care Center in Hungary
por: Tóth, Gábor, et al.
Publicado: (2020)

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020
por: Kiss, Zoltán, et al.
Publicado: (2023)

Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
por: Géczi, Lajos, et al.
Publicado: (2020)

Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary
por: Major, Tamás, et al.
Publicado: (2021)

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
por: Kiss, Zoltán, et al.
Publicado: (2022)

Consumer acceptance of genetic-based personalized nutrition in Hungary
por: Szakály, Zoltán, et al.
Publicado: (2021)

The Role of Hemoglobin Oxidation Products in Triggering Inflammatory Response Upon Intraventricular Hemorrhage in Premature Infants
por: Erdei, Judit, et al.
Publicado: (2020)

May Measurement Month 2019: an analysis of blood pressure screening results from Hungary
por: Nemcsik, János, et al.
Publicado: (2021)

Exploring park visitation trends during the Covid-19 pandemic in Hungary by using mobile device location data
por: Csomós, György, et al.
Publicado: (2023)

Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study
por: Nagy, György, et al.
Publicado: (2022)

Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
por: Vokó, Zoltán, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ve583l6b76lbvkp50densdn21a